126 filings
Page 5 of 7
424B4
eyemib561n2mv6btj
1 Oct 20
Prospectus supplement with pricing info
4:21pm
EFFECT
iii ymlszoc455g
1 Oct 20
Notice of effectiveness
12:15am
CORRESP
shk7px6c7dcwh ypwv
28 Sep 20
Correspondence with SEC
12:00am
CORRESP
a4yy8ezv33zscw5u
28 Sep 20
Correspondence with SEC
12:00am
UPLOAD
hb79p4y5frfde
23 Sep 20
Letter from SEC
12:00am
DRS
88wll9g8gugib72
18 Sep 20
Draft registration statement
12:00am
DRSLTR
9fsk155pj3217z0 98s
18 Sep 20
Correspondence regarding draft registration statement
12:00am
8-K
gnwe6 pixsvy
12 Aug 20
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
7:30am
8-K
a8w0qp
29 Jun 20
Regulation FD Disclosure
9:28am
10-Q
7f7l85 3ubqe42m7e
12 May 20
Quarterly report
4:14pm
8-K
q4tp1vkgmycgg43qj
12 May 20
Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results
10:52am
10-K
1rllmhy78d
30 Mar 20
Annual report
5:26pm
8-K
kq6svdijvj6nuuqlid
30 Mar 20
Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results
6:45am
S-8
0snk7h4zq2rjyqvuz3
24 Feb 20
Registration of securities for employees
12:00am
8-K
x4w4n49ohwk
11 Feb 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
36kks38l9
7 Feb 20
Prospectus supplement with pricing info
12:00am
EFFECT
5oyewpx34
6 Feb 20
Notice of effectiveness
12:15am
S-1MEF
ix6 8v4es
5 Feb 20
Registration of additional securities for an S-1
9:17pm